{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:36:33Z","timestamp":1794267393210,"version":"4.9.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T00:00:00Z","timestamp":1759104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82171071, 81870667"],"award-info":[{"award-number":["82171071, 81870667"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Fundamental Research Funds for the Central Universities","award":["project number YG2025ZD26"],"award-info":[{"award-number":["project number YG2025ZD26"]}]},{"name":"Program of Shanghai Academic\/Technology Research Leader under the Science and Technology Innovation Action Plan","award":["21XD1402700"],"award-info":[{"award-number":["21XD1402700"]}]},{"name":"the Clinical Research Plan of Shenkang Hospital Development Center of Shanghai","award":["No. SHDC2022CRD001"],"award-info":[{"award-number":["No. SHDC2022CRD001"]}]},{"name":"National Clinical Key Specialty Construction Project","award":["10000015Z155080000004"],"award-info":[{"award-number":["10000015Z155080000004"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"DOI":"10.1186\/s12944-025-02735-y","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T17:01:57Z","timestamp":1759165317000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Dysregulated serum lipid profiles in neovascular age-related macular degeneration revealed by UPLC\u2012MS\/MS lipidomics"],"prefix":"10.1186","volume":"24","author":[{"given":"Yuan","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyin","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xindan","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinchen","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,29]]},"reference":[{"key":"2735_CR1","doi-asserted-by":"publisher","first-page":"e106","DOI":"10.1016\/S2214-109X(13)70145-1","volume":"2","author":"WL Wong","year":"2014","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health. 2014;2:e106\u2013116.","journal-title":"Lancet Glob Health"},{"key":"2735_CR2","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(22)02609-5","volume":"401","author":"RH Guymer","year":"2023","unstructured":"Guymer RH, Campbell TG. Age-related macular degeneration. Lancet. 2023;401:1459\u201372.","journal-title":"Lancet"},{"key":"2735_CR3","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.preteyeres.2016.04.002","volume":"53","author":"CW Wong","year":"2016","unstructured":"Wong CW, Yanagi Y, Lee WK, Ogura Y, Yeo I, Wong TY, Cheung CMG. Age-related macular degeneration and polypoidal choroidal vasculopathy in Asians. Prog Retin Eye Res. 2016;53:107\u201339.","journal-title":"Prog Retin Eye Res"},{"key":"2735_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","volume":"128","author":"CMG Cheung","year":"2021","unstructured":"Cheung CMG, Lai TYY, Teo K, Ruamviboonsuk P, Chen SJ, Kim JE, Gomi F, Koh AH, Kokame G, Jordan-Yu JM, et al. Polypoidal choroidal vasculopathy: consensus nomenclature and Non-Indocyanine green angiograph diagnostic criteria from the Asia-Pacific ocular imaging society PCV workgroup. Ophthalmology. 2021;128:443\u201352.","journal-title":"Ophthalmology"},{"key":"2735_CR5","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1038\/s41467-023-41256-z","volume":"14","author":"Q Fan","year":"2023","unstructured":"Fan Q, Li H, Wang X, Tham YC, Teo KYC, Yasuda M, Lim WK, Kwan YP, Teo JX, Chen CJ, et al. Contribution of common and rare variants to Asian neovascular age-related macular degeneration subtypes. Nat Commun. 2023;14:5574.","journal-title":"Nat Commun"},{"key":"2735_CR6","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2019.11.004","volume":"127","author":"RF Spaide","year":"2020","unstructured":"Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda SR, Staurenghi G, Waheed NK, Chakravarthy U, Rosenfeld PJ, Holz FG, et al. Consensus nomenclature for reporting neovascular Age-Related macular degeneration data: consensus on neovascular Age-Related macular degeneration nomenclature study group. Ophthalmology. 2020;127:616\u201336.","journal-title":"Ophthalmology"},{"key":"2735_CR7","doi-asserted-by":"crossref","unstructured":"Bo Q, Zhang M, Chen J, Jia H, Shen M, Sun M, Xu M, Feng J, Yan Q, Yu Y et al. Progression of Polypoidal Lesions Associated with Exudative Recurrence in Polypoidal Choroidal Vasculopathy. Ophthalmology 2022.","DOI":"10.1016\/j.ophtha.2022.09.013"},{"key":"2735_CR8","doi-asserted-by":"publisher","first-page":"105319","DOI":"10.1016\/j.compbiomed.2022.105319","volume":"143","author":"D Ma","year":"2022","unstructured":"Ma D, Kumar M, Khetan V, Sen P, Bhende M, Chen S, Yu TTL, Lee S, Navajas EV, Matsubara JA, et al. Clinical explainable differential diagnosis of polypoidal choroidal vasculopathy and age-related macular degeneration using deep learning. Comput Biol Med. 2022;143:105319.","journal-title":"Comput Biol Med"},{"key":"2735_CR9","doi-asserted-by":"crossref","unstructured":"Sheth JU, Stewart MW, Narayanan R, Anantharaman G, Chandran K, Lai TYY, Chakravarthy U, Das T. Macular neovascularization. Surv Ophthalmol 2024.","DOI":"10.1016\/j.survophthal.2024.08.003"},{"key":"2735_CR10","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.ophtha.2017.11.019","volume":"125","author":"CMG Cheung","year":"2018","unstructured":"Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK, Wong TY. Polypoidal choroidal vasculopathy: definition, pathogenesis, diagnosis, and management. Ophthalmology. 2018;125:708\u201324.","journal-title":"Ophthalmology"},{"key":"2735_CR11","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1001\/jamaophthalmol.2018.1804","volume":"136","author":"WK Lee","year":"2018","unstructured":"Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell P, Cheung GCM, Zhang Z, Leal S, Ishibashi T, Investigators P. Efficacy and safety of intravitreal Aflibercept for polypoidal choroidal vasculopathy in the PLANET study: A randomized clinical trial. JAMA Ophthalmol. 2018;136:786\u201393.","journal-title":"JAMA Ophthalmol"},{"key":"2735_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ajo.2019.02.027","volume":"204","author":"TY Wong","year":"2019","unstructured":"Wong TY, Ogura Y, Lee WK, Iida T, Chen SJ, Mitchell P, Gemmy Cheung CM, Zhang Z, Leal S, Ishibashi T, Investigators P. Efficacy and safety of intravitreal Aflibercept for polypoidal choroidal vasculopathy: Two-Year results of the Aflibercept in polypoidal choroidal vasculopathy study. Am J Ophthalmol. 2019;204:80\u2013 89.","journal-title":"Am J Ophthalmol"},{"key":"2735_CR13","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.survophthal.2023.04.002","volume":"68","author":"A Hatamnejad","year":"2023","unstructured":"Hatamnejad A, Patil NS, Mihalache A, Popovic MM, Kertes PJ, Muni RH, Wong DT. Efficacy and safety of anti-vascular endothelial growth agents for the treatment of polypoidal choroidal vasculopathy: A systematic review and meta-analysis. Surv Ophthalmol. 2023;68:920\u201328.","journal-title":"Surv Ophthalmol"},{"key":"2735_CR14","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1001\/jamaophthalmol.2020.2443","volume":"138","author":"TH Lim","year":"2020","unstructured":"Lim TH, Lai TYY, Takahashi K, Wong TY, Chen LJ, Ruamviboonsuk P, Tan CS, Lee WK, Cheung CMG, Ngah NF, et al. Comparison of Ranibizumab with or without verteporfin photodynamic therapy for polypoidal choroidal vasculopathy: the EVEREST II randomized clinical trial. JAMA Ophthalmol. 2020;138:935\u201342.","journal-title":"JAMA Ophthalmol"},{"key":"2735_CR15","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1001\/jamaophthalmol.2019.5628","volume":"138","author":"B Doble","year":"2020","unstructured":"Doble B, Finkelstein EA, Tian Y, Saxena N, Patil S, Wong TY, Cheung CMG. Cost-effectiveness of intravitreal Ranibizumab with verteporfin photodynamic therapy compared with Ranibizumab monotherapy for patients with polypoidal choroidal vasculopathy. JAMA Ophthalmol. 2020;138:251\u201359.","journal-title":"JAMA Ophthalmol"},{"key":"2735_CR16","doi-asserted-by":"publisher","first-page":"38342","DOI":"10.1038\/srep38342","volume":"6","author":"M Li","year":"2016","unstructured":"Li M, Zhang X, Liao N, Ye B, Peng Y, Ji Y, Wen F. Analysis of the serum lipid profile in polypoidal choroidal vasculopathy. Sci Rep. 2016;6:38342.","journal-title":"Sci Rep"},{"key":"2735_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s12979-020-00205-w","volume":"17","author":"M Chen","year":"2020","unstructured":"Chen M, Yang N, Lechner J, Toth L, Hogg R, Silvestri G, Chakravarthy U, Xu H. Plasma level of Lipocalin 2 is increased in neovascular age-related macular degeneration patients, particularly those with macular fibrosis. Immun Ageing. 2020;17:35.","journal-title":"Immun Ageing"},{"issue":"Suppl","key":"2735_CR18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/aos.15226","volume":"100","author":"PH Gabrielle","year":"2022","unstructured":"Gabrielle PH. Lipid metabolism and retinal diseases. Acta Ophthalmol. 2022;100(Suppl):3\u201343.","journal-title":"Acta Ophthalmol"},{"key":"2735_CR19","doi-asserted-by":"crossref","unstructured":"Hansman DS, Du J, Casson RJ, Peet DJ. Eye on the horizon: the metabolic landscape of the RPE in aging and disease. Prog Retin Eye Res 2025 Jan; 104:101306.","DOI":"10.1016\/j.preteyeres.2024.101306"},{"key":"2735_CR20","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1093\/ije\/dyaa178","volume":"50","author":"X Han","year":"2021","unstructured":"Han X, Ong J-S, Hewitt AW, Gharahkhani P, MacGregor S. The effects of eight serum lipid biomarkers on age-related macular degeneration risk: a Mendelian randomization study. Int J Epidemiol. 2021;50:325\u201336.","journal-title":"Int J Epidemiol"},{"key":"2735_CR21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1186\/s12944-024-02337-0","volume":"23","author":"B Tong","year":"2024","unstructured":"Tong B, Long C, Zhang J, Zhang X, Li Z, Qi H, Su K, Zhang D, Chen Y, Ling J, et al. Associations of human blood metabolome with optic neurodegenerative diseases: a bi-directionally systematic Mendelian randomization study. Lipids Health Dis. 2024;23:359.","journal-title":"Lipids Health Dis"},{"key":"2735_CR22","doi-asserted-by":"publisher","first-page":"101037","DOI":"10.1016\/j.preteyeres.2021.101037","volume":"89","author":"D Lewandowski","year":"2022","unstructured":"Lewandowski D, Sander CL, Tworak A, Gao F, Xu Q, Skowronska-Krawczyk D. Dynamic lipid turnover in photoreceptors and retinal pigment epithelium throughout life. Prog Retin Eye Res. 2022;89:101037.","journal-title":"Prog Retin Eye Res"},{"key":"2735_CR23","doi-asserted-by":"publisher","first-page":"101781","DOI":"10.1016\/j.redox.2020.101781","volume":"37","author":"LX Tan","year":"2020","unstructured":"Tan LX, Germer CJ, La Cunza N, Lakkaraju A. Complement activation, lipid metabolism, and mitochondrial injury: converging pathways in age-related macular degeneration. Redox Biol. 2020;37:101781.","journal-title":"Redox Biol"},{"key":"2735_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41572-021-00265-2","volume":"7","author":"M Fleckenstein","year":"2021","unstructured":"Fleckenstein M, Keenan TDL, Guymer RH, Chakravarthy U, Schmitz-Valckenberg S, Klaver CC, Wong WT, Chew EY. Age-related macular degeneration. Nat Rev Dis Primers. 2021;7:31.","journal-title":"Nat Rev Dis Primers"},{"key":"2735_CR25","doi-asserted-by":"publisher","first-page":"100858","DOI":"10.1016\/j.preteyeres.2020.100858","volume":"79","author":"K Kaarniranta","year":"2020","unstructured":"Kaarniranta K, Uusitalo H, Blasiak J, Felszeghy S, Kannan R, Kauppinen A, Salminen A, Sinha D, Ferrington D. Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog Retin Eye Res. 2020;79:100858.","journal-title":"Prog Retin Eye Res"},{"key":"2735_CR26","doi-asserted-by":"publisher","first-page":"101231","DOI":"10.1016\/j.preteyeres.2023.101231","volume":"98","author":"SX Zhang","year":"2024","unstructured":"Zhang SX, Wang JJ, Starr CR, Lee EJ, Park KS, Zhylkibayev A, Medina A, Lin JH, Gorbatyuk M. The Endoplasmic reticulum: homeostasis and crosstalk in retinal health and disease. Prog Retin Eye Res. 2024;98:101231.","journal-title":"Prog Retin Eye Res"},{"key":"2735_CR27","doi-asserted-by":"publisher","first-page":"101263","DOI":"10.1016\/j.preteyeres.2024.101263","volume":"101","author":"Y Sun","year":"2024","unstructured":"Sun Y, Li F, Liu Y, Qiao D, Yao X, Liu GS, Li D, Xiao C, Wang T, Chi W. Targeting inflammasomes and pyroptosis in retinal diseases-molecular mechanisms and future perspectives. Prog Retin Eye Res. 2024;101:101263.","journal-title":"Prog Retin Eye Res"},{"key":"2735_CR28","doi-asserted-by":"publisher","first-page":"100142","DOI":"10.1016\/j.xops.2022.100142","volume":"2","author":"Y Yanagi","year":"2022","unstructured":"Yanagi Y, Yu RMC, Ahamed W, Yu M, Teo KYC, Tan ACS, Cheng CY, Wong TY, Apte RS, Cheung CMG. Serum cholesterol efflux capacity in Age-Related macular degeneration and polypoidal choroidal vasculopathy. Ophthalmol Sci. 2022;2:100142.","journal-title":"Ophthalmol Sci"},{"key":"2735_CR29","doi-asserted-by":"crossref","unstructured":"Theodoridis K, Gika H, Kotali A. Acylcarnitines in ophthalmology: promising emerging biomarkers. Int J Mol Sc i. 2022;23(24):16183.","DOI":"10.3390\/ijms232416183"},{"key":"2735_CR30","doi-asserted-by":"crossref","unstructured":"Brown CN, Green BD, Thompson RB, den Hollander AI. Lengyel I, consortium E-R: metabolomics and Age-Related macular degeneration. Metabolites 2018;9.","DOI":"10.3390\/metabo9010004"},{"key":"2735_CR31","doi-asserted-by":"publisher","first-page":"e20329","DOI":"10.1016\/j.heliyon.2023.e20329","volume":"9","author":"T Zhao","year":"2023","unstructured":"Zhao T, Li J, Wang Y, Guo X, Sun Y. Integrative metabolome and lipidome analyses of plasma in neovascular macular degeneration. Heliyon. 2023;9:e20329.","journal-title":"Heliyon"},{"key":"2735_CR32","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1167\/iovs.61.8.32","volume":"61","author":"G Liew","year":"2020","unstructured":"Liew G, Tse B, Ho IV, Joachim N, White A, Pickford R, Maltby D, Gopinath B, Mitchell P, Crossett B. Acylcarnitine abnormalities implicate mitochondrial dysfunction in patients with neovascular Age-Related macular degeneration. Invest Ophthalmol Vis Sci. 2020;61:32.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2735_CR33","first-page":"37","volume":"66","author":"Y Chen","year":"2025","unstructured":"Chen Y, Zhang X, Zhang Y, Zhang S, Huo Y, Wu Y, Shen L, Mao J. Metabolomic characteristics of aqueous humor in wet Age-Related macular degeneration and the impact of Anti-VEGF treatment. Invest Ophthalmol Vis Sci. 2025;66:37.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2735_CR34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1167\/iovs.64.3.28","volume":"64","author":"CK Yoon","year":"2023","unstructured":"Yoon CK, Kim YA, Park UC, Kwon SH, Lee Y, Yoo HJ, Seo JH, Yu HG. Vitreous fatty amides and acyl carnitines are altered in intermediate Age-Related macular degeneration. Invest Ophthalmol Vis Sci. 2023;64:28.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2735_CR35","doi-asserted-by":"publisher","first-page":"109160","DOI":"10.1016\/j.exer.2022.109160","volume":"222","author":"B Liu","year":"2022","unstructured":"Liu B, Cong C, Li Z, Hao L, Yuan X, Wang W, Shi Y, Liu T. Analysis of the aqueous humor lipid profile in patients with polypoidal choroidal vasculopathy. Exp Eye Res. 2022;222:109160.","journal-title":"Exp Eye Res"},{"key":"2735_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/0014-5793(94)00811-6","volume":"351","author":"M Alberghina","year":"1994","unstructured":"Alberghina M, Infarinato S, Anfuso CD, Lupo G. 1-Acyl-2-lysophosphatidylcholine transport across the blood-retina and blood-brain barrier. FEBS Lett. 1994;351:181\u20135.","journal-title":"FEBS Lett"},{"key":"2735_CR37","doi-asserted-by":"crossref","unstructured":"Terao R, Kaneko H. Lipid signaling in ocular neovascularization. Int J Mol Sci .2020 Jul 4;21(13):4758.,","DOI":"10.3390\/ijms21134758"},{"key":"2735_CR38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.ophtha.2017.08.008","volume":"125","author":"I Lains","year":"2018","unstructured":"Lains I, Kelly RS, Miller JB, Silva R, Vavvas DG, Kim IK, Murta JN, Lasky-Su J, Miller JW, Husain D. Human plasma metabolomics study across all stages of Age-Related macular degeneration identifies potential lipid biomarkers. Ophthalmology. 2018;125 (2):245\u201354.","journal-title":"Ophthalmology"},{"key":"2735_CR39","doi-asserted-by":"publisher","first-page":"e12915","DOI":"10.1111\/acel.12915","volume":"18","author":"RD Semba","year":"2019","unstructured":"Semba RD, Zhang P, Adelnia F, Sun K, Gonzalez-Freire M, Salem N Jr., Brennan N, Spencer RG, Fishbein K, Khadeer M, et al. Low plasma lysophosphatidylcholines are associated with impaired mitochondrial oxidative capacity in adults in the Baltimore longitudinal study of aging. Aging Cell. 2019;18:e12915.","journal-title":"Aging Cell"},{"key":"2735_CR40","doi-asserted-by":"crossref","unstructured":"Law SH, Chan ML, Marathe GK, Parveen F, Chen CH, Ke LY. An updated review of lysophosphatidylcholine metabolism in human diseases. Int J Mol Sci. 2019;20(5):1149.","DOI":"10.3390\/ijms20051149"},{"key":"2735_CR41","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s41065-024-00356-6","volume":"161","author":"ZY Liu","year":"2024","unstructured":"Liu ZY, Zhang H, Sun XL, Liu JY. Causal association between metabolites and age-related macular degeneration: a bidirectional two-sample Mendelian randomization study. Hereditas. 2024;161:51.","journal-title":"Hereditas"},{"key":"2735_CR42","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1038\/s41433-022-02016-3","volume":"36","author":"L Chen","year":"2022","unstructured":"Chen L, Yang P, Curcio CA. Visualizing lipid behind the retina in aging and age-related macular degeneration, via indocyanine green angiography (ASHS-LIA). Eye (Lond). 2022;36:1735\u2013 1746.","journal-title":"Eye (Lond)"},{"key":"2735_CR43","doi-asserted-by":"publisher","first-page":"2102","DOI":"10.1167\/iovs.19-26968","volume":"60","author":"L Chen","year":"2019","unstructured":"Chen L, Zhang X, Li M, Liao N, Wen F. Age-Related scattered hypofluorescent spots on Late-Phase indocyanine green angiography as precursor lesions of polypoidal choroidal vasculopathy. Invest Ophthalmol Vis Sci. 2019;60:2102\u201309.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2735_CR44","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1038\/s41419-024-06762-y","volume":"15","author":"S Zhou","year":"2024","unstructured":"Zhou S, Taskintuna K, Hum J, Gulati J, Olaya S, Steinman J, Golestaneh N. PGC-1alpha repression dysregulates lipid metabolism and induces lipid droplet accumulation in retinal pigment epithelium. Cell Death Dis. 2024;15:385.","journal-title":"Cell Death Dis"},{"key":"2735_CR45","doi-asserted-by":"crossref","unstructured":"Yako T, Otsu W, Nakamura S, Shimazawa M, Hara H. Lipid droplet accumulation promotes RPE dysfunction. Int J Mol Sci . 2022 Feb 4;23(3):1790 .","DOI":"10.3390\/ijms23031790"},{"key":"2735_CR46","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12886-017-0555-7","volume":"17","author":"D Luo","year":"2017","unstructured":"Luo D, Deng T, Yuan W, Deng H, Jin M. Plasma metabolomic study in Chinese patients with wet age-related macular degeneration. BMC Ophthalmol. 2017;17:165.","journal-title":"BMC Ophthalmol"},{"key":"2735_CR47","doi-asserted-by":"publisher","first-page":"e15123","DOI":"10.1016\/j.heliyon.2023.e15123","volume":"9","author":"Y Shen","year":"2023","unstructured":"Shen Y, Wang H, Fang J, Liu K, Xu X. Novel insights into the mechanisms of hard exudate in diabetic retinopathy: findings of serum lipidomic and metabolomics profiling. Heliyon. 2023;9:e15123.","journal-title":"Heliyon"},{"key":"2735_CR48","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1021\/acs.jproteome.9b00574","volume":"19","author":"K Liu","year":"2020","unstructured":"Liu K, Fang J, Jin J, Zhu S, Xu X, Xu Y, Ye B, Lin SH, Xu X. Serum metabolomics reveals personalized metabolic patterns for macular neovascular disease patient stratification. J Proteome Res. 2020;19:699\u2013707.","journal-title":"J Proteome Res"},{"key":"2735_CR49","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s12886-018-0812-4","volume":"18","author":"J Jing","year":"2018","unstructured":"Jing J, Yinchen S, Xia C, Jing W, Chong C, Xun X, Hengye H, Kun L. Pharmacogenomic study on anti-VEGF medicine in treatment of macular neovascular diseases: a study protocol for a prospective observational study. BMC Ophthalmol. 2018;18:181.","journal-title":"BMC Ophthalmol"},{"key":"2735_CR50","doi-asserted-by":"crossref","unstructured":"Li M, Shi Y, Chen Q, Hu G, Xie J, Ye L, Fan Y, Zhu J, He J, Xu X. Peripapillary atrophy area predicts the decrease of macular choroidal thickness in young adults during myopia progression. BMJ Open Ophthalmol. 2024;9(1):e001555 .","DOI":"10.1136\/bmjophth-2023-001555"},{"key":"2735_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00592-019-01363-0","volume":"57","author":"H Wang","year":"2020","unstructured":"Wang H, Fang J, Chen F, Sun Q, Xu X, Lin SH, Liu K. Metabolomic profile of diabetic retinopathy: a GC-TOFMS-based approach using vitreous and aqueous humor. Acta Diabetol. 2020;57:41\u201351.","journal-title":"Acta Diabetol"},{"key":"2735_CR52","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.jchf.2023.07.028","volume":"11","author":"V Kodogo","year":"2023","unstructured":"Kodogo V, Viljoen C, Hoevelmann J, Chakafana G, Tromp J, Farhan HA, Goland S, van der Meer P, Karaye K, Kryczka K, et al. Proteomic profiling in patients with peripartum cardiomyopathy: A biomarker study of the ESC EORP PPCM registry. JACC Heart Fail. 2023;11:1708\u201325.","journal-title":"JACC Heart Fail"},{"key":"2735_CR53","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1194\/jlr.M073684","volume":"58","author":"CMG Cheung","year":"2017","unstructured":"Cheung CMG, Gan A, Fan Q, Chee ML, Apte RS, Khor CC, Yeo I, Mathur R, Cheng CY, Wong TY, Tai ES. Plasma lipoprotein subfraction concentrations are associated with lipid metabolism and age-related macular degeneration. J Lipid Res. 2017;58:1785\u201396.","journal-title":"J Lipid Res"},{"key":"2735_CR54","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/ng.3448","volume":"48","author":"LG Fritsche","year":"2016","unstructured":"Fritsche LG, Igl W, Bailey JN, Grassmann F, Sengupta S, Bragg-Gresham JL, Burdon KP, Hebbring SJ, Wen C, Gorski M, et al. A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants. Nat Genet. 2016;48:134\u201343.","journal-title":"Nat Genet"},{"key":"2735_CR55","doi-asserted-by":"publisher","first-page":"6063","DOI":"10.1038\/ncomms7063","volume":"6","author":"CY Cheng","year":"2015","unstructured":"Cheng CY, Yamashiro K, Chen LJ, Ahn J, Huang L, Huang L, Cheung CM, Miyake M, Cackett PD, Yeo IY, et al. New loci and coding variants confer risk for age-related macular degeneration in East Asians. Nat Commun. 2015;6:6063.","journal-title":"Nat Commun"},{"key":"2735_CR56","doi-asserted-by":"publisher","first-page":"4978","DOI":"10.1167\/iovs.18-25137","volume":"59","author":"SL Mitchell","year":"2018","unstructured":"Mitchell SL, Uppal K, Williamson SM, Liu K, Burgess LG, Tran V, Umfress AC, Jarrell KL, Cooke Bailey JN, Agarwal A, et al. The carnitine shuttle pathway is altered in patients with neovascular Age-Related macular degeneration. Invest Ophthalmol Vis Sci. 2018;59:4978\u201385.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2735_CR57","doi-asserted-by":"crossref","unstructured":"Mitchell SL, Ma C, Scott WK, Agarwal A, Pericak-Vance MA, Haines JL, Jones DP, Uppal K, Brantley MA. Jr. plasma metabolomics of intermediate and neovascular Age-Related macular degeneration patients. Cells. 2021;10(11):3141.","DOI":"10.3390\/cells10113141"},{"key":"2735_CR58","doi-asserted-by":"crossref","unstructured":"de la Chao JM, Rondet-Courbis B, Ferre M, Muller J, Buisset A, Leruez S, Plubeau G, Mace T, Moureauzeau L, Chupin S et al. A plasma metabolomic profiling of exudative Age-Related macular degeneration showing carnosine and mitochondrial deficiencies. J Clin Med. 2020;9.","DOI":"10.3390\/jcm9030631"},{"key":"2735_CR59","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.plipres.2014.01.002","volume":"54","author":"J Ecker","year":"2014","unstructured":"Ecker J, Liebisch G. Application of stable isotopes to investigate the metabolism of fatty acids, glycerophospholipid and sphingolipid species. Prog Lipid Res. 2014;54:14\u201331.","journal-title":"Prog Lipid Res"},{"key":"2735_CR60","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1093\/advances\/nmaa024","volume":"11","author":"RD Semba","year":"2020","unstructured":"Semba RD. Perspective: the potential role of Circulating lysophosphatidylcholine in neuroprotection against alzheimer disease. Adv Nutr. 2020;11:760\u201372.","journal-title":"Adv Nutr"},{"key":"2735_CR61","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s12944-018-0954-7","volume":"18","author":"RD Semba","year":"2019","unstructured":"Semba RD, Moaddel R, Cotch MF, Jonasson F, Eiriksdottir G, Harris TB, Launer LJ, Sun K, Klein R, Schaumberg DA, et al. Serum lipids in adults with late age-related macular degeneration: a case-control study. Lipids Health Dis. 2019;18:7.","journal-title":"Lipids Health Dis"},{"key":"2735_CR62","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/nrm.2017.107","volume":"19","author":"YA Hannun","year":"2018","unstructured":"Hannun YA, Obeid LM. Sphingolipids and their metabolism in physiology and disease. Nat Rev Mol Cell Biol. 2018;19:175\u201391.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2735_CR63","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cmet.2021.06.006","volume":"33","author":"CD Green","year":"2021","unstructured":"Green CD, Maceyka M, Cowart LA, Spiegel S. Sphingolipids in metabolic disease: the good, the bad, and the unknown. Cell Metab. 2021;33:1293\u20131306.","journal-title":"Cell Metab"},{"key":"2735_CR64","doi-asserted-by":"publisher","first-page":"100037","DOI":"10.1194\/jlr.TR120000972","volume":"62","author":"MV Simon","year":"2021","unstructured":"Simon MV, Basu SK, Qaladize B, Grambergs R, Rotstein NP, Mandal N. Sphingolipids as critical players in retinal physiology and pathology. J Lipid Res. 2021;62:100037.","journal-title":"J Lipid Res"},{"key":"2735_CR65","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1167\/iovs.16-19717","volume":"57","author":"J Fan","year":"2016","unstructured":"Fan J, Wu BX, Crosson CE. Suppression of acid Sphingomyelinase protects the retina from ischemic injury. Invest Ophthalmol Vis Sci. 2016;57:4476\u201384.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2735_CR66","doi-asserted-by":"publisher","first-page":"4422","DOI":"10.1167\/iovs.09-5134","volume":"51","author":"RS Brush","year":"2010","unstructured":"Brush RS, Tran JT, Henry KR, McClellan ME, Elliott MH, Mandal MN. Retinal sphingolipids and their very-long-chain fatty acid-containing species. Invest Ophthalmol Vis Sci. 2010;51:4422\u201331.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"2735_CR67","doi-asserted-by":"publisher","first-page":"110303","DOI":"10.1016\/j.exer.2025.110303","volume":"254","author":"D Skowronska-Krawczyk","year":"2025","unstructured":"Skowronska-Krawczyk D, Finnemann SC, Grant MB, Held K, Hu Z, Lu YR, Malek G, Sennlaub F, Sparrow J. D\u2019Amore PA: features that distinguish age-related macular degeneration from aging. Exp Eye Res. 2025;254:110303.","journal-title":"Exp Eye Res"},{"key":"2735_CR68","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/978-3-031-27681-1_6","volume":"1415","author":"A Kotnala","year":"2023","unstructured":"Kotnala A, Anderson DMG, Messinger JD, Curcio CA, Schey KL. Untargeted lipidomic profiling of aged human retina with and without Age-Related macular degeneration (AMD). Adv Exp Med Biol. 2023;1415:37\u201342.","journal-title":"Adv Exp Med Biol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-025-02735-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-025-02735-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T18:08:13Z","timestamp":1759169293000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-025-02735-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,29]]},"references-count":68,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2735"],"URL":"https:\/\/doi.org\/10.1186\/s12944-025-02735-y","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,29]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine (No. 2016KY115-2) and registered on ClinicalTrials.gov (NCT03128463).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"302"}}